All Type of News
“It is lawful to suspend qualification of doctors who received rebates disguised as research expenses”
A doctor ‘C’ who issued prescriptions without treating patients for millions of wons as research and investigation expenses from pharmaceutical companies applied for an administrative litigation, but finally failed.
...
This year’s pharmaceutical export goal to be set at USD 6.42 billion
With domestic pharmaceutical companies’ aggressive pioneering to foreign markets, this year’s foreign pharmaceutical exports will hit USD 6.418 billion, expected to grow 10% up compared to the last year.
The Korea Ph...
160 pharmaceutical companies from 19 countries share technology
The opening ceremony of an international pharmaceutical event, CPhI, is coming up in 3 weeks.
‘CPhI Korea 2016,’ which will be held at the D Hall of Seoul COEX from the 23rd(TUE) to 25th(THU) of August, is jointly h...
Pharmaceutical distribution field nervous over fierce competition
While fierce competition among pharmaceutical distribution companies over clients is being developed, a concern was raised that survival cannot be guaranteed if companies are not able to adapt environmental changes. T...
President Moo-jin Choo in crisis as participating in presidential visit to telemedicine
The healthcare industry has criticized President Moo-jin Choo of the Korean Medical Association over accompanying to the President Geun-hye Park’s visit to a senior center implementing the telemedicine demo project.
...
‘Rebate’ a way for patent-expired original products to survive
Ethicality of large global companies branched in Korea has been severely damaged after the Oxy’s humidifier disinfectant crisis and the Novartis’ rebate crisis.
Most of all, since multinational pharmaceutical compan...
Kolmar Korea & Abbott Korea sign exclusive license of 2 CNS drugsOn the 27th, Kolmar Korea(President Dong-han Yoon) announced the company concluded an CMO(contract manufacturing organization) agreement of 2 types of central nervous system(CNS...
|
Hospitalist Project starts on September
The demo project for hospitalist, experts specializing in hospitalization, will start to be implemented from this September.
This is because the Ministry of Health and Welfare(MOHW) announced the hospitalist project ...
Pharmaceutical MRs, “Doctors won’t let us meet unless paying medical fees”
“I have no time. Pay the fees to see me.”
The sales tradition of the pharmaceutical field is getting merciless.
Since an endless number of rebate investigations and scandals have been exposed, doctors have shown co...
Reason why multinational pharmaceutical companies focus on skin disease market
The skin disease market is one of the fields with high potential.
Since interests in general skin problems and incurable diseases, such as atopy and psoriasis, are rapidly increased, multinational pharmaceutical com...
